A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice

Blood

Volumn 117, Issue 21, 2011, Pages 5663-5673

  Sato, Kei ^a   Misawa, Naoko ^a   Nie, Chuanyi ^a   Satou, Yorifumi ^a   Iwakiri, Dai ^b   Matsuoka, Masao ^a   Takahashi, Rei ^c,d   Kuzushima, Kiyotaka ^e   Ito, Mamoru ^f   Takada, Kenzo ^b   Koyanagi, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS DNA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE STORM; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOPATHOLOGY; LEUKOCYTOSIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA; VIREMIA;

EID: 79957623393     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-305979     Document Type: Article

References (47)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields Virology. Vol. 2 (5th ed). Philadelphia, PA: Lippincott Williams & Wilkins; 2007:2655-2700.
2. Cohen JI. Epstein-Barr virus infections, including infectious mononucleosis. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's Principals of Internal Medicine. Vol. 1 (15th ed) New York, NY: McGraw-Hill; 2001:1109-1111.
3. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001;98(6):1882-1888.
4. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007; 7(12):814-822. (Pubitemid 350152044)
5. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol. 1994;144(6):1219-1225.
6. Créput C, Galicier L, Buyse S, Azoulay E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008; 34(7):1177-1187.
7. Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21(5):245-253. (Pubitemid 47212601)
8. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957- 1959. (Pubitemid 129515904)
9. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20(2):129-135. (Pubitemid 28455444)
10. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110-114. (Pubitemid 44684766)
11. Dupré L, Andolfi G, Tangye SG, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood. 2005;105(11):4383- 4389. (Pubitemid 40720785)
12. Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104(3):735-743. (Pubitemid 38970567)
13. Wu C, Nguyen KB, Pien GC, et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol. 2001;2(5):410-414. (Pubitemid 33706138)
14. Brown DE, McCoy MW, Pilonieta MC, Nix RN, Detweiler CS. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis. PLoS ONE. 2010;5(2):e9441.
15. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44(3):993-1002. (Pubitemid 10242233)
16. + cells with Epstein-Barr virus. J Virol. 2004;78(24):13891-13900.
17. Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12(11):1316-1322. (Pubitemid 44706935)
18. Strowig T, Gurer C, Ploss A, et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009;206(6):1423-1434.
19. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104-107. (Pubitemid 38451466)
20. Yajima M, Imadome K, Nakagawa A, et al. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis. 2009;200(10):1611-1615.
21. Yajima M, Imadome KI, Nakagawa A, et al. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis. 2008;198(5):673-682.
22. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/ SCID/gammacnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182. (Pubitemid 35217065)
23. Nie C, Sato K, Misawa N, et al. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL- 2Rgammanull mice. Virology. 2009;394(1):64-72.
24. Sato K, Izumi T, Misawa N, et al. Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol. 2010;84(18):9546-9556.
25. Sato K, Nie C, Misawa N, Tanaka Y, Ito M, Koyanagi Y. Dynamics of memory and naive CD8+ T lymphocytes in humanized NOD/SCID/ IL-2Rgammanull mice infected with CCR5-tropic HIV-1. Vaccine. 2010;28(suppl 2):B32-37.
26. Shimizu N, Yoshiyama H, Takada K. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol. 1996;70(10):7260-7263. (Pubitemid 26307449)
27. Sato K, Aoki J, Misawa N, et al. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J Virol. 2008;82(2):1021-1033.
28. Sato K, Yamamoto SP, Misawa N, Yoshida T, Miyazawa T, Koyanagi Y. Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology. 2009;6:53.
29. Miura Y, Misawa N, Maeda N, et al. Critical contribution of tumor necrosis factor-related apoptosisinducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NODSCID mice. J Exp Med. 2001;193(5):651-659. (Pubitemid 32539562)
30. Jebbink J, Bai X, Rogers BB, Dawson DB, Scheuermann RH, Domiati-Saad R. Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J Mol Diagn. 2003;5(1):15-20. (Pubitemid 36192995)
31. Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med. 2009;206(10):2091-2099.
32. Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol. 1996;48(2-3):175-181. (Pubitemid 26078643)
33. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587-617. (Pubitemid 46697918)
34. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431. (Pubitemid 27169287)
35. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16(4):251-261. (Pubitemid 44140721)
36. Epstein MA, Hunt RD, Rabin H. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I Reticuloproliferative disease in an inoculated animal. Int J Cancer. 1973;12(2):309-318.
37. Epstein MA, Rabin H, Ball G, Rickinson AB, Jarvis J, Melendez LV. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). II. EB virus in a cell line from an animal with reticuloproliferative disease. Int J Cancer. 1973;12(2):319-332.
38. Mosier DE. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. J Clin Immunol. 1990;10(4):185-191. (Pubitemid 20258682)
39. Shope T, Dechairo D, Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A. 1973;70(9):2487-2491.
40. Takashima K, Ohashi M, Kitamura Y, et al. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J Med Virol. 2008;80(3):455-466. (Pubitemid 351206895)
41. Wedderburn N, Edwards JM, Desgranges C, Fontaine C, Cohen B, de Thé G. Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J Infect Dis. 1984;150(6):878-882. (Pubitemid 15182142)
42. van Lier RA, ten Berge IJ, Gamadia LE. Human CD8+ T-cell differentiation in response to viruses. Nat Rev Immunol. 2003;3(12):931-939.
43. Lim WH, Kireta S, Russ GR, Coates PT. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood. 2007;109(3):1043-1050. (Pubitemid 46220650)
44. Schmidt KN, Leung B, Kwong M, et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol. 2004;172(1):138-143. (Pubitemid 38020465)
45. Tabiasco J, Devevre E, Rufer N, et al. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol. 2006;177(12):8708-8713. (Pubitemid 44893836)
46. Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998;4(9):1065-1067. (Pubitemid 28417341)
47. Watanabe S, Terashima K, Ohta S, et al. Hematopoietic stem cell-engrafted NOD/SCID/ IL2Rgammanull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007;109(1):212-218. (Pubitemid 46070123)